Heron Therapeutics PE Ratio 2006-2020 | HRTX

Current and historical p/e ratio for Heron Therapeutics (HRTX) from 2006 to 2020. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Heron Therapeutics PE ratio as of July 01, 2020 is 0.00.
Heron Therapeutics PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2020-07-01 16.04 0.00
2020-03-31 11.74 $-2.27 0.00
2019-12-31 23.50 $-2.50 0.00
2019-09-30 18.50 $-2.48 0.00
2019-06-30 18.59 $-2.55 0.00
2019-03-31 24.44 $-2.46 0.00
2018-12-31 25.94 $-2.47 0.00
2018-09-30 31.65 $-2.93 0.00
2018-06-30 38.85 $-3.21 0.00
2018-03-31 27.60 $-3.47 0.00
2017-12-31 18.10 $-3.66 0.00
2017-09-30 16.15 $-3.79 0.00
2017-06-30 13.85 $-4.26 0.00
2017-03-31 15.00 $-4.63 0.00
2016-12-31 13.10 $-4.55 0.00
2016-09-30 17.23 $-4.20 0.00
2016-06-30 18.05 $-3.59 0.00
2016-03-31 18.99 $-3.16 0.00
2015-12-31 26.70 $-2.94 0.00
2015-09-30 24.40 $-2.78 0.00
2015-06-30 31.16 $-2.81 0.00
2015-03-31 14.55 $-2.85 0.00
2014-12-31 10.06 $-2.89 0.00
2014-09-30 8.33 $-2.93 0.00
2014-06-30 12.32 $-3.07 0.00
2014-03-31 13.91 $-3.29 0.00
2013-12-31 8.90 $-3.35 0.00
2013-09-30 6.70 $-3.20 0.00
2013-06-30 7.18 $-2.80 0.00
2013-03-31 7.40 $-2.20 0.00
2012-12-31 10.90 $-1.80 0.00
2012-09-30 12.44 $-1.20 0.00
2012-06-30 13.70 $-1.20 0.00
2012-03-31 7.40 $-1.80 0.00
2011-12-31 4.60 $-2.20 0.00
2011-09-30 5.20 $-3.00 0.00
2011-06-30 4.80 $-3.40 0.00
2011-03-31 4.60 $-4.20 0.00
2010-12-31 9.02 $-3.60 0.00
2010-09-30 12.00 $-3.80 0.00
2010-06-30 12.20 $-3.80 0.00
2010-03-31 20.40 $-4.60 0.00
2009-12-31 25.20 $-6.40 0.00
2009-09-30 17.00 $-8.00 0.00
2009-06-30 18.80 $-11.20 0.00
2009-03-31 10.80 $-12.60 0.00
2008-12-31 8.40 $-15.00 0.00
2008-09-30 15.00 $-17.40 0.00
2008-06-30 22.80 $-16.40 0.00
2008-03-31 25.00 $-16.20 0.00
2007-12-31 31.60 $-31.00 0.00
2007-09-30 41.00 $-43.60 0.00
2007-06-30 43.80 $-52.60 0.00
2007-03-31 83.04 $-63.20 0.00
2006-12-31 109.60 $16.80 6.52
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.333B $0.146B
Heron Therapeutics Inc. is a specialty pharmaceutical company. The company is developing products using its proprietary Biochronomer (TM) polymer-based drug delivery platform. Its product portfolio includes APF530, is being developed for the prevention of acute chemotherapy-induced nausea and vomiting. Heron Therapeutics Inc., formerly known as A.P. Pharma, Inc., is based in REDWOOD CITY CA.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $65.086B 36.94
Takeda Pharmaceutical (TAK) Japan $56.529B 9.91
Astellas Pharma (ALPMY) Japan $31.017B 15.72
Eisai (ESALY) Japan $23.530B 20.40
UCB SA (UCBJF) Belgium $22.485B 0.00
Merck (MKGAF) Germany $14.895B 19.53
Grifols, S.A (GRFS) Spain $12.541B 15.59
Catalent (CTLT) United States $11.354B 43.89
Neurocrine Biosciences (NBIX) United States $11.330B 52.36
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $9.945B 0.00
Ono Pharmaceutical (OPHLF) Japan $9.254B 19.78
Ionis Pharmaceuticals (IONS) United States $8.214B 43.67
IPSEN SA ADR (IPSEY) France $6.994B 0.00
Orion OYJ (ORINY) Finland $6.766B 30.32
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.664B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.107B 9.77
United Therapeutics (UTHR) United States $5.325B 10.09
STADA ARZNEIMI (STDAF) Germany $4.916B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $4.396B 479.89
Nektar Therapeutics (NKTR) United States $4.122B 0.00
Evotec AG (EVTCY) Germany $4.062B 109.59
Hypermarcas (HYPMY) Brazil $3.800B 11.56
FibroGen (FGEN) United States $3.611B 0.00
ChemoCentryx (CCXI) United States $3.559B 0.00
PTC Therapeutics (PTCT) United States $3.322B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.544B 10.45
Pacira BioSciences (PCRX) United States $2.210B 45.23
Sage Therapeutics (SAGE) United States $2.159B 0.00
Cronos Group (CRON) Canada $2.097B 60.10
Corcept Therapeutics (CORT) United States $1.928B 19.11
Indivior (INVVY) United States $1.904B 23.64
Xencor (XNCR) United States $1.846B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.830B 0.00
Akebia Therapeutics (AKBA) United States $1.769B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.645B 12.59
USANA Health Sciences (USNA) United States $1.543B 15.82
Zogenix (ZGNX) United States $1.495B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.425B 15.35
Esperion Therapeutics (ESPR) United States $1.417B 0.00
Portola Pharmaceuticals (PTLA) United States $1.412B 0.00
Karyopharm Therapeutics (KPTI) United States $1.385B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.324B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.250B 0.00
Translate Bio (TBIO) United States $1.127B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.004B 44.83
Tilray (TLRY) Canada $0.888B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.841B 0.00
ImmunoGen (IMGN) United States $0.802B 0.00
Endo (ENDP) Ireland $0.788B 1.22
Aerie Pharmaceuticals (AERI) United States $0.686B 0.00
Trillium Therapeutics (TRIL) Canada $0.675B 0.00
VAXART, INC (VXRT) United States $0.657B 0.00
Radius Health (RDUS) United States $0.632B 0.00
Molecular Templates (MTEM) United States $0.631B 0.00
Ardelyx (ARDX) United States $0.615B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.608B 0.00
Collegium Pharmaceutical (COLL) United States $0.601B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.575B 0.00
Flexion Therapeutics (FLXN) United States $0.507B 0.00
Siga Technologies (SIGA) United States $0.479B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.478B 11.55
Innate Pharma SA (IPHYF) France $0.476B 0.00
DURECT (DRRX) United States $0.455B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.450B 17.56
Ocular Therapeutix (OCUL) United States $0.445B 0.00
MEI Pharma (MEIP) United States $0.438B 0.00
Harpoon Therapeutics (HARP) United States $0.415B 0.00
Organogenesis Holdings (ORGO) United States $0.407B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.394B 0.00
Calithera Biosciences (CALA) United States $0.372B 0.00
OptiNose (OPTN) United States $0.342B 0.00
TherapeuticsMD (TXMD) United States $0.340B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.308B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.303B 0.00
Concert Pharmaceuticals (CNCE) United States $0.295B 0.00
Lannett Co Inc (LCI) United States $0.293B 6.42
PROFOUND MEDICL (PROF) Canada $0.272B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.262B 0.00
CASI Pharmaceuticals (CASI) United States $0.252B 0.00
Redhill Biopharma (RDHL) Israel $0.236B 0.00
Jounce Therapeutics (JNCE) United States $0.235B 5.61
Rafael Holdings (RFL) United States $0.227B 0.00
Taiwan Liposome (TLC) Taiwan $0.225B 0.00
KalVista Pharmaceuticals (KALV) United States $0.216B 0.00
IMV INC (IMV) Canada $0.190B 0.00
Nivalis Therapeutics (ALPN) United States $0.180B 0.00
Nature's Sunshine Products (NATR) United States $0.175B 23.10
Altimmune (ALT) United States $0.166B 0.00
Aquestive Therapeutics (AQST) United States $0.163B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.153B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.116B 0.00
Champions Oncology (CSBR) United States $0.114B 0.00
Otonomy (OTIC) United States $0.112B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.110B 0.00
Recro Pharma (REPH) United States $0.107B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.106B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.101B 0.00
Xeris Pharmaceuticals (XERS) United States $0.100B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.098B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.096B 0.00
Onconova Therapeutics (ONTX) United States $0.095B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.095B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.095B 0.00
Sundial Growers (SNDL) Canada $0.086B 0.00
CTI BioPharma (CTIC) United States $0.085B 0.00
Hemispherx BioPharma (AIM) United States $0.081B 0.00
MediWound (MDWD) Israel $0.081B 0.00
SCYNEXIS (SCYX) United States $0.074B 0.00
Biomerica (BMRA) United States $0.072B 0.00
Heat Biologics (HTBX) United States $0.071B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.070B 0.00
Aclaris Therapeutics (ACRS) United States $0.068B 0.00
CV Sciences (CVSI) United States $0.062B 0.00
Lipocine (LPCN) United States $0.060B 0.00
RENEURON GP (RNUGF) United Kingdom $0.057B 0.00
Infinity Pharmaceuticals (INFI) United States $0.052B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.051B 30.27
Addex Therapeutics (ADXN) Switzerland $0.048B 0.00
PolarityTE (PTE) United States $0.048B 0.00
Natural Alternatives (NAII) United States $0.046B 0.00
GTx (ONCT) United States $0.044B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.043B 0.00
Forward Pharma (FWP) Denmark $0.042B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.040B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.038B 82.09
Novan (NOVN) United States $0.038B 0.00
IsoRay (ISR) United States $0.038B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.038B 0.00
AgeX Therapeutics (AGE) United States $0.036B 0.00
Mannatechorporated (MTEX) United States $0.035B 6.70
Neos Therapeutics (NEOS) United States $0.034B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.033B 0.00
ElectroCore (ECOR) United States $0.031B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.030B 0.00
Jaguar Animal Health (JAGX) United States $0.029B 0.00
India Globalization Capital (IGC) United States $0.024B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.022B 0.00
Bio-Path Holdings (BPTH) United States $0.019B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.018B 0.00
Flex Pharma (SLRX) United States $0.018B 0.00
Can-Fite Biopharma (CANF) Israel $0.017B 0.00
Iterum Therapeutics (ITRM) Ireland $0.017B 0.00
ProPhase Labs (PRPH) United States $0.017B 0.00
Shineco (TYHT) China $0.015B 0.00
China SXT Pharmaceuticals (SXTC) China $0.015B 0.00
Regulus Therapeutics (RGLS) United States $0.014B 0.00
Cyanotech (CYAN) United States $0.014B 33.29
Sonoma Pharmaceuticals (SNOA) United States $0.013B 0.00
RXi Pharmaceuticals (PHIO) United States $0.010B 0.00
Vical (BBI) United States $0.010B 0.00
HANCOCK JAFFE (HJLI) United States $0.009B 0.00
Midatech Pharma (MTP) United Kingdom $0.009B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.009B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00